Acumen Pharmaceuticals, Inc.ABOSNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-114.02M
↓ 168% below average
Average (5y)
$-42.62M
Historical baseline
Range
High:$-7.80M
Low:$-114.02M
CAGR
+71.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-114.02M | -86.5% |
| 2023 | $-61.14M | -35.2% |
| 2022 | $-45.24M | -131.0% |
| 2021 | $-19.58M | -147.5% |
| 2020 | $-7.91M | -1.4% |
| 2019 | $-7.80M | - |